Progression free survival Kaplan-Meier analysis of published ovarian cancer microarray dataset (N = 1435) by “Kaplan-Meier Plotter (kmplot.com)” 17 showed that high ADAR1 protein level strongly correlated with a poor outcome, whereas low ADAR1 protein level was associated with good progression free survival (Fig. 1f, P < 0.01). This evidence concerns the gene ADAR and ovarian carcinoma.